Article info

Download PDFPDF
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

Authors

  • Estela García-Martín Pharmacy Department, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain PubMed articlesGoogle scholar articles
  • RM Romero-Jiménez Pharmacy Department, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Ofelia Baniandrés-Rodríguez Dermatology Department, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Vicente Escudero-Vilaplana Pharmacy Department, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Juana Benedí-González Pharmacology, Pharmacognosy and Botany Department, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Paloma Morales de los Ríos Luna Dermatology Department, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • Ana Herranz-Alonso Pharmacy Department, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  • María Sanjurjo-Sáez Pharmacy Department, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Mrs Estela García-Martín; egarciamartin{at}salud.madrid.org
View Full Text

Citation

García-Martín E, Romero-Jiménez R, Baniandrés-Rodríguez O, et al
Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

Publication history

  • Received October 25, 2022
  • Accepted April 3, 2023
  • First published April 24, 2023.
Online issue publication 
August 22, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.